Transcatheter arterial embolization for spontaneous rupture of hepatocellular carcinoma.
Kuni Ohtomo, Shigeru Furui, T Kokubo, T Yamauchi, N Yashiro, Y Itai, Masahiro Iio
Abstract
Kuni Ohtomo, Shigeru Furui, T Kokubo, T Yamauchi, N Yashiro, Y Itai, Masahiro Iio
Abstract
Transcatheter arterial embolization (TAE) was performed in 20 patients with ruptured hepatocellular carcinoma (HCC). Bleeding was improved in all patients, but only four survived for over three months. Rerupture occurred in seven patients (35%) and the prognosis was extremely poor. TAE should be considered the treatment of choice for ruptured HCC; however, long-term survival was limited to those patients without portal extension of HCC. The severity of rupture also influenced the prognosis.
OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Transcatheter arterial embolization (TAE) was performed in 20 patients with ruptured hepatocellular carcinoma (HCC). Bleeding was improved in all patients, but only four survived for over three months. Rerupture occurred in seven patients (35%) and the prognosis was extremely poor. TAE should be considered the treatment of choice for ruptured HCC; however, long-term survival was limited to those patients without portal extension of HCC. The severity of rupture also influenced the prognosis.
Key concepts: Medicine, Arterial Embolization, Hepatocellular carcinoma, Embolization, Carcinoma, Radiology, Transarterial embolization, Surgery